Prevelance, Predictors and Outcome of Sepsis Associated Liver Injury (SALI)

计划入组 100 人 · 首次发布于 2025 年 1 月 6 日

Microbiome and Enteric Signatures in Sepsis-associated Hepatorenal Injury

计划入组 200 人 · 首次发布于 2026 年 7 月 29 日

Investigations Into Sepsis-associated Acute Kidney Injury

计划入组 20 人 · 首次发布于 2023 年 1 月 23 日

MLCK inhibitors (sepsis/tissue injury)

GalNAc-conjugated siRNA therapeutic (liver injury/NAFLD)

inter alpha inhibitor proteins (sepsis/brain injury/necrotizing enterocolitis)

Associated Capital

United States

LIVER INSTITUTE PLLC

United States

National Liver Institute

Egypt

Elevated Red Cell Distribution Width Linked to Increased Mortality in Sepsis-Associated Liver Injury

CDSCO Panel Approves Novartis Protocol Amendment for TIN816 Study in Sepsis-Associated Acute Kidney Injury

AM-Pharma Completes Phase 2 Enrollment for Ilofotase Alfa in Cardiac Surgery-Associated Kidney Injury Prevention